What is the Affinity Chromatography Market Size in 2026?
The global affinity chromatography market is witnessing steady growth, driven by the increasing demand for biologics and advanced purification technologies. The market size was valued at USD 3.90 billion in 2025 and is projected to grow from USD 4.24 billion in 2026 to approximately USD 8.98 billion by 2035, expanding at a CAGR of 8.70% during the forecast period.
This growth is primarily fueled by rising investments in drug development, increasing prevalence of chronic diseases, and the growing need for efficient, scalable, and high-specificity purification methods for biomolecules such as proteins and antibodies.
Read Also: Desalting Buffer Exchange Market
Market Overview
Affinity chromatography is a highly specialized purification technique used to isolate biomolecules—including proteins, nucleic acids, and antigens—based on specific biological interactions. This method relies on the reversible binding between a target molecule and a ligand attached to a stationary phase.
The market encompasses a wide range of products such as resins, columns, kits, and reagents, along with advanced instruments and services. It plays a vital role in biopharmaceutical production, diagnostics, and life sciences research, especially in downstream processing where high purity is essential.
With the rapid expansion of biotechnology and increasing adoption of monoclonal antibody therapies, affinity chromatography has become an indispensable tool in modern drug development and manufacturing.
Key Takeaways
- North America dominated the market with a 38% share in 2025
- Asia Pacific is expected to grow at the fastest CAGR
- Resins segment led the market with 58% share
- Protein A affinity chromatography held 48% share
- Antibody purification was the leading application
- Pharmaceutical & biotechnology companies accounted for 60% market share
Affinity Chromatography Market Trends
The market is evolving rapidly with several emerging trends shaping its future:
1. Rising Demand for Advanced Techniques
There is increasing adoption of Protein A/G/L affinity chromatography and IMAC (Immobilized Metal Affinity Chromatography) for applications beyond drug manufacturing, including diagnostics and research.
2. Growth in Biologics Production
The surge in production of monoclonal antibodies, vaccines, and recombinant proteins is significantly boosting demand for high-specificity purification technologies.
3. Technological Advancements
Innovations in ligands and resin materials are improving binding capacity, efficiency, and scalability, enabling faster and more cost-effective purification processes.
4. Shift Toward Disposable Systems
Single-use chromatography systems are gaining popularity due to their ability to reduce cross-contamination and eliminate cleaning validation requirements.
5. Expansion in Emerging Markets
Growing healthcare infrastructure and increased biotechnology investments in developing regions are creating new growth opportunities.
Market Dynamics
Market Drivers
Growing Demand for Biopharmaceuticals
The increasing prevalence of chronic diseases and aging populations is driving the demand for biologics and vaccines. Monoclonal antibodies and recombinant proteins account for a significant portion of therapeutic pipelines, boosting the need for advanced purification technologies.
Increased R&D Investments
Pharmaceutical and biotech companies are investing heavily in research and development, further accelerating the adoption of affinity chromatography.
Market Restraints
Regulatory Challenges and Complexity
Affinity chromatography processes must comply with strict regulatory standards for purity and safety. Complex workflows, high validation requirements, and the need for skilled professionals can limit adoption.
Market Opportunities
Adoption of Automation
Automation is transforming the industry by improving productivity, reducing manual intervention, and ensuring reproducibility. Automated affinity systems enhance process efficiency and reduce operational risks.
Segment Insights
By Product
Resins Segment Dominance
The resins segment accounted for the largest share of 58% in 2025. Their high specificity, scalability, and binding capacity make them essential for purifying complex biopharmaceuticals.
Columns Segment Growth
Columns held a 22% share and are expected to grow significantly due to their reproducibility, high flow rates, and suitability for large-scale production.
Kits & Reagents
This segment is projected to grow at the fastest rate due to increasing demand for ready-to-use purification solutions in research and drug development.
By Application
Antibody Purification Leads
This segment dominated the market due to the increasing demand for high-purity monoclonal antibodies used in therapeutics and diagnostics.
Vaccine Production Growth
The vaccine production segment is expected to grow rapidly due to the need for scalable and efficient purification methods during disease outbreaks.
Protein Purification
Affinity chromatography enables high recovery rates of active proteins, making it essential in early-stage drug discovery.
By Technique
Protein A Affinity Chromatography
Holding 48% market share, this technique is widely used for monoclonal antibody purification due to its high specificity and efficiency.
IMAC Segment
The second-largest segment, IMAC, is gaining traction due to its versatility and cost-effectiveness in recombinant protein purification.
Dye-Ligand & Immunoaffinity Techniques
These methods offer cost-effective and highly specific purification options, supporting niche and specialized applications.
By End User
Pharmaceutical & Biotechnology Companies
This segment dominated with a 60% share, driven by high biologics production and extensive R&D investments.
Academic & Research Institutes
These institutions are key contributors due to increasing research in genomics and proteomics.
CROs (Contract Research Organizations)
CROs are expected to witness the fastest growth due to outsourcing trends in drug development.
Regional Insights
North America
North America held the largest share of 38% in 2025, supported by:
- Advanced biopharmaceutical infrastructure
- High R&D investments
- Strong regulatory frameworks
The U.S. remains a key contributor due to its leadership in biologics development and adoption of advanced purification technologies.
Asia Pacific
Asia Pacific is expected to grow at the fastest rate due to:
- Expanding biopharmaceutical manufacturing
- Government initiatives supporting biotech innovation
- Rising presence of CDMOs
Countries like China and India are investing heavily in biotechnology infrastructure, driving regional growth.
Europe
Europe accounted for 29% of the market and is supported by:
- Strong pharmaceutical manufacturing base
- High demand for biologics and biosimilars
- Strict regulatory standards
Germany leads the region with its advanced research infrastructure and growing biotech ecosystem.
Competitive Landscape
The affinity chromatography market is highly competitive, with key players focusing on innovation, product development, and strategic collaborations. Major companies include:
- Cytiva (Danaher Corporation)
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Sartorius AG
- Agilent Technologies, Inc.
- Repligen Corporation
- Pall Corporation
Recent Developments
- June 2025: Ecolab Life Sciences launched Purolite AP+50 resin, offering high binding capacity and durability for antibody purification.
- May 2025: Waters Corporation introduced BioResolve Protein A columns with advanced technology for improved accuracy in large molecule separations.
Conclusion
The affinity chromatography market is poised for strong growth, driven by increasing demand for biologics, advancements in purification technologies, and expanding pharmaceutical R&D activities. As the industry moves toward automation, single-use systems, and continuous bioprocessing, affinity chromatography will remain a cornerstone technology in biopharmaceutical manufacturing.
With rapid expansion in emerging markets and continuous innovation by key players, the market is expected to nearly double by 2035, offering significant opportunities for stakeholders across the value chain.
Get Sample: https://www.precedenceresearch.com/sample/8277
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com